These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21089417)

  • 21. [Thiazolidinediones--new antidiabetic agents. Why don't we know how to use them?].
    Gale EA
    Ugeskr Laeger; 2001 Dec; 163(50):7032-5. PubMed ID: 11794032
    [No Abstract]   [Full Text] [Related]  

  • 22. [Oral antidiabetic drugs in 2003].
    Ducobu J
    Rev Med Brux; 2003 Sep; 24(4):A361-8. PubMed ID: 14606302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insulin and oral antidiabetic drugs. How to combine them in type 2 diabetes?].
    Lotz N
    MMW Fortschr Med; 2000 May; 142(18):45-8. PubMed ID: 10851870
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of oral hypoglycemic agents in patients with chronic kidney failure].
    Libardi F; Sirolli V; Cappelli P; Bonomini M
    G Ital Nefrol; 2009; 26(6):679-85. PubMed ID: 19918750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
    Pernet A; Bäbler M; Ganz K
    Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy with oral antidiabetic agents -- special considerations in the case of coronary heart disease].
    Nauck MA; Matthaei S
    Dtsch Med Wochenschr; 2005 Apr; 130(17):1091-6. PubMed ID: 15841424
    [No Abstract]   [Full Text] [Related]  

  • 27. Evolving concepts of type 2 diabetes management with oral medications: new approaches to an old disease.
    Henry RR
    Curr Med Res Opin; 2008 Aug; 24(8):2189-202. PubMed ID: 18573228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral hypoglycaemic agents. When, how and why.
    Harris P; Colagiuri S
    Aust Fam Physician; 1997 Apr; 26(4):391-6. PubMed ID: 9115112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
    Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L
    Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oral antidiabetic drugs--1. For each patient the proper drug].
    Bachmann W
    MMW Fortschr Med; 2000 Mar; 142(9):41-4. PubMed ID: 10795481
    [No Abstract]   [Full Text] [Related]  

  • 31. The stepwise approach to the management of type 2 diabetes.
    Warren RE
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S3-8. PubMed ID: 15315864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic management of type 2 diabetes: a review for dentistry.
    Little JW; Rhodus NL
    Gen Dent; 2007; 55(6):564-71; quiz 572-3, 599-600. PubMed ID: 18050585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving oral pharmacologic treatment and management of type 2 diabetes.
    Dailey GE
    Manag Care; 2004 Feb; 13(2):41-7. PubMed ID: 15004930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
    Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
    Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ
    Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined oral therapy for type 2 diabetes.
    Mehnert H
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):405-6. PubMed ID: 15372358
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of type 2 diabetes. Critical evaluation of oral antidiabetic drugs].
    Landgraf R
    MMW Fortschr Med; 2000 May; 142(21):33-7. PubMed ID: 10872292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Update on new oral treatment for diabetes].
    Awad J; Schindel B; Schindel Y
    Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents.
    Anselmino M
    J Diabetes Complications; 2009; 23(6):427-33. PubMed ID: 18768334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.